Why the study?
Cardiotoxicity remains a common radiotherapy complication, and the efficacy of atorvastatin against late cardiac effects following clinically relevant partial-heart radiation exposure required evaluation.
Does atorvastatin prevent late radiation-induced cardiotoxicity in a mouse model of partial-heart radiation exposure?
Population
Female, 12-week old, C57BL/6j mice receiving an image-guided 16 Gy X-ray field to the heart base
Comparison
Atorvastatin vs no atorvastatin
Design
Preclinical animal study
Follow-up
50 weeks
Authors
Loading...
Atorvastatin may protect against late radiation cardiotoxicity; leaves open confirmation in human trials before any practice change.
Does atorvastatin prevent late radiation-induced cardiotoxicity in a mouse model of partial-heart radiation exposure?
Atorvastatin prevents left ventricular systolic dysfunction and cardiac conduction perturbations following partial heart irradiation in a murine model, suggesting potential for cardioprotection during thoracic radiotherapy.
Walls et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: